Vikrant Rachakonda, M.D. for UC Davis Health

Vikrant Rachakonda, M.D.

Associate Professor, Division of Gastroenterology and Hepatology

To see if Vikrant Rachakonda is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Internal Medicine


Transplant Hepatology


Internal Medicine

Locations and Contact

UC Davis Midtown Ambulatory Care Center

Midtown GI Clinic
3160 Folsom Blvd
Sacramento, CA 95816

Get Directions

Phone: 916-734-0779

Mather VA Mental Health

Sacramento VA Medical Center
10535 Hospital Way
Mather, CA 95755

Get Directions

Additional Numbers

Clinic Phone


Clinic Phone


Clinic Fax


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

My overall goal is to deliver compassionate care to patients with liver disease. There is a misconception that many liver diseases, including alcohol-related liver disease, are self-inflicted conditions. I try to ensure patients get fair, unbiased, expert care of their liver diseases to promote long-term health.

Clinical Interests

Dr. Rachakonda is hepatologist and gastroenterologist providing care for adults with all liver diseases. He is a board-certified in transplant hepatology; he has a special clinical interest in alcohol related liver disease and liver transplantation. Dr. Rachakonda sees patients at the Northern California VA Medical Center in Mather, California. His practice at UC Davis is limited to outpatient endoscopy and inpatient hepatology consultation. 

Research/Academic Interests

Dr. Rachakonda's research focuses on improving the care of patients with alcohol-related liver diseases through studies of interleukin-6 signaling as a driver of hepatocellular dysfunction. He also has an interest in access to care for patients with alcohol-related liver disease.


Gastroenterology and Hepatology

Undergraduate School

B.S., Physics, Johns Hopkins University, Baltimore MD 2002

Medical School

M.D., University of Pittsburgh School of Medicine, Pittsburgh PA 2007


Internal Medicine, Barnes-Jewish Hospital, Washington University, St. Louis MO 2007-2010


Gastroenterology and Hepatology, University of Maryland Medical Center, Baltimore MD 2010-2013


NIH T32 Postdoctoral Fellow, Gastroenterology and Hepatology, University of Maryland Medical Center, Baltimore MD 2011-2013


NIH T32 Postdoctoral Fellow, Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh PA 2013-2014


Transplant Hepatology Fellowship Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh PA 2014-2015

Division of Gastroenterology Faculty Teaching Award, University of Pittsburgh Medical Center, 2020

Champion of Nursing Award, University of Pittsburgh Medical Center, 2020

Fellow Teacher of the Year, University of Maryland Medical Center, 2012

Phi Beta Kappa, Johns Hopkins University, 2002

Molinari M, Fernandez-Carrillo C, Dai D, Dana J, Clemente-Sanchez A, Dharmayan S, Kaltenmeier C, Liu H, Behari J, Rachakonda V, Ganesh S, Hughes C, Tevar A, Al Harakeh H, Emmanuel B, Humar A, Bataller R. Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. Transpl Int. 2021 Jun;34(6):1105-1122. doi:10.1111/tri.13873. Epub 2021 May 5. PMID:33780554.

Kaltenmeier C, Jorgensen D, Dharmayan S, Ayloo S, Rachakonda V, Geller DA, Tohme S, Molinari M. The liver transplant risk score prognosticates the outcomes of liver transplant recipients at listing. HPB (Oxford). 2021 Jun;23(6):927-936. doi:10.1016/j.hpb.2020.10.002. Epub 2020 Nov 11. PMID:33189566.

Argemi J, Ventura-Cots M, Rachakonda V, Bataller R. Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments. Rev Esp Enferm Dig. 2020 Nov;112(11):869-878. doi:10.17235/reed.2020.7242/2020. PMID:33054302.

Arnouk J, Rachakonda VP, Jaiyeola D, Behari J. Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity. Hepatol Commun. 2020 Jul 21;4(10):1419-1429. doi:10.1002/hep4.1572. PMID:33024913.

Rachakonda V, Bataller R, Duarte-Rojo A. Recent advances in alcoholic hepatitis. F1000Res. 2020 Feb 10;9:F1000 Faculty Rev-97. doi:10.12688/f1000research.20394.1. PMID:32089834.

Cannella R, Minervini MI, Rachakonda V, Bollino G, Furlan A. Liver stiffness measurement in patients with nodular regenerative hyperplasia undergoing magnetic resonance elastography. Abdom Radiol (NY). 2020 Feb;45(2):373-383. doi:10.1007/s00261-019-02367-8. PMID:31834457.

Fu CP, Ali H, Rachakonda VP, Oczypok EA, DeLany JP, Kershaw EE. The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women. PLoS One. 2019 Nov 26;14(11):e0224942. doi:10.1371/journal.pone.0224942. PMID:31770380.

Rachakonda VP, DeLany JP, Kershaw EE, Behari J. Impact of Hepatic Steatosis on Resting Metabolic Rate and Metabolic Adaptation in Response to Intentional Weight Loss. Hepatol Commun. 2019 Aug 21;3(10):1347-1355. doi:10.1002/hep4.1414. PMID:31592493.

Arnouk J, Mathew D, Nulton E, Rachakonda V. A Celiac Disease Phenotype After Checkpoint Inhibitor Exposure: An Example of Immune Dysregulation After Immunotherapy. ACG Case Rep J. 2019 Aug 8;6(8):e00158. doi:10.14309/crj.0000000000000158. PMID:31737699.